Medical device makers, health information technology providers and AdvaMed together spent more than $20 million lobbying Congress, the White House and the Food & Drug Administration during the fourth quarter.

The FDA posted notice of a Class I recall of a hemodialysis system distributed by Baxter International Inc., warning that in extreme cases the machine’s defect could result in serious injuries or death.